Allon Therapeutics, Inc. reported unaudited earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported a net loss of $1,071,311 or $0.01 per share compared to $2,778,704 or $0.03 per share a year ago, representing a decrease in net loss of $1,707,393.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 14.11K | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NPCUF Stock
- News Allon Therapeutics Inc.
- Allon Therapeutics, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2013